Desio, Italy

Marco Berna

USPTO Granted Patents = 2 

 


Average Co-Inventor Count = 3.0

ph-index = 1


Location History:

  • Muggio, IT (2012)
  • Desio, IT (2020)

Company Filing History:


Years Active: 2012-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovator Marco Berna: Pioneer in Slow-Release Nutraceuticals**

Introduction

Marco Berna, an inventive mind located in Desio, Italy, has made significant strides in the field of nutraceutical and pharmaceutical compositions. Known for his commitment to enhancing the effectiveness of oral medications, Berna holds two patents that showcase his innovative approaches to drug formulations.

Latest Patents

Marco Berna's latest patents include groundbreaking advancements in slow-release solid oral compositions. His first patent details a composition that features a core donor of methyl groups alongside a mix of pharmaceutically acceptable excipients. A key aspect of this invention is its unique outer coating, which comprises shellac and magnesium stearate. This innovative design allows the methyl group donor, primarily S-adenosylmethionine (SAMe), to pass through the gastric barrier intact, releasing its benefits gradually throughout the digestive tract.

His second patent focuses on the stability of S-adenosylmethionine salts. This invention presents new salts of SAMe that demonstrate improved stability while containing at least 70% by weight of the active ingredient. This advancement not only enhances the usability of SAMe in various clinical settings but also improves the formulation process, making it a valuable asset in pharmaceutical development.

Career Highlights

Marco Berna has made a notable impact while working at Gnosis Spa, a company recognized for its focus on innovation in nutraceuticals and pharmaceuticals. His work is characterized by meticulous research and an aptitude for addressing complex challenges in drug delivery systems.

Collaborations

Throughout his career, Berna has collaborated with esteemed colleagues such as Daniele Giovannone and Niccolò Miraglia. These partnerships have fostered a dynamic environment, encouraging knowledge sharing and the pursuit of innovative solutions in their field.

Conclusion

In conclusion, Marco Berna stands out as a formidable inventor in the realm of slow-release nutraceuticals. His contributions through his two patents underline a commitment to advancing the pharmaceutical industry, emphasizing the importance of effective and stable drug formulations. As he continues to explore new horizons, Marco Berna's work will undoubtedly leave a lasting impact on healthcare and patient treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…